제 품 PRODUCT

Tell your healthcare provider today if you (or your child): might not be seeing as well as prior to starting SABRIL; begin to journey, run into points, or are more clumsy than typical vigabatrin negative effects; are shocked by individuals or points can be found in front of you that seem ahead out of nowhere; or if your child is acting in different ways than typical.

The Vigabatrin REMS Program is needed by the FDA to guarantee notified risk-benefit decisions before starting therapy, and to make sure proper use of vigabatrin while patients are treated. When vision loss will take place, it is not possible for your health care carrier to recognize.

It is suggested that your healthcare provider examination your (or your youngster's) vision prior to or within 4 weeks after beginning SABRIL and at least every 3 months throughout treatment until SABRIL is stopped. Tell your doctor if you or your child have any side effect that bothers you or that does not disappear.

If you are expectant or plan to get expectant, inform your health care carrier. If vision testing can not be done, your healthcare provider may proceed recommending SABRIL, but will certainly not be able to look for any vision loss. If vision examinations are refrained from doing frequently, your healthcare provider may quit prescribing SABRIL for you (or your youngster).